SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-015315
Filing Date
2023-04-27
Accepted
2023-04-27 16:30:34
Documents
7
Period of Report
2023-06-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A igm_def14a_2023.htm DEF 14A 1910351
2 GRAPHIC img221931477_0.jpg GRAPHIC 128304
3 GRAPHIC img221931477_1.jpg GRAPHIC 142208
4 GRAPHIC img221931477_2.jpg GRAPHIC 141645
5 GRAPHIC img221931477_3.jpg GRAPHIC 102300
6 GRAPHIC img221931477_4.jpg GRAPHIC 474435
7 GRAPHIC img221931477_5.jpg GRAPHIC 361372
  Complete submission text file 0000950170-23-015315.txt   3752082
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39045 | Film No.: 23857574
SIC: 2834 Pharmaceutical Preparations